The Bardet-Biedl syndrome (BBS) community will have two major opportunities in the coming weeks to come together, connect, and…
Articles by Marisa Horak MS
The approved therapy Imcivree (setmelanotide) was associated with reduced hunger and improvements in weight-related measures among children with…
Imcivree (setmelanotide), Rhythm Pharmaceuticals’ anti obesity drug, is now approved in the United Kingdom to help promote weight loss…
Since Imcivree (setmelanotide) was approved in the U.S. in March to support weight loss in people ages 4 and…
An 11-year-old girl in England with Bardet-Biedl syndrome (BBS) has become the second person ever to receive…
A newly published expert review has confirmed trial data — from a late-stage study dubbed TRANSCEND — showing that treatment…
A Race Against Blindness, a nonprofit dedicated to funding research into Bardet-Biedl syndrome (BBS) and other inherited conditions…
People with Bardet-Biedl syndrome (BBS) caused by a mutation called p.(Met390Arg) in both copies of the BBS1 gene may…
Genetic susceptibility toward obesity has little impact on whether lifestyle interventions aimed at weight loss are successful in children who…
People who are genetically predisposed toward obesity or having high levels of so-called “bad” cholesterol — low-density lipoprotein (LDL)…